⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 19 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 52 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 13 minutes ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 19 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 52 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 13 minutes ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
🧸 Product IT March 8, 2024

Matrix — Matrix Biolage Colorcare therapie

Mask cream marketed for coloured hair, 150 ml.

📷 Safety Gate / European Commission · Source
Matrix — Matrix Biolage Colorcare therapie
📷 Safety Gate / European Commission · Source
Risk level
Serious risk
Type
Chemical
Category
Cosmetics
Hazard
According to the list of ingredients, the product contains 2-(4-tert-butylbenzyl) propionaldehyde (BMHCA), which is prohibited in cosmetic products. BMHCA can damage the reproductive system, may harm the health of the unborn child and may cause skin sensitisation.
Origin
United States

⚖️ Actions ordered by authorities

  • ▸ (to: Distributor) Ban on the marketing of the product and any accompanying measures
Barcode (GTIN): 884486004635
🗄
Archived (older alert)
This alert was reported 874 days ago and has been moved from our active feed to the archive. The original safety information still applies — we have no confirmation from the issuing agency that the product is safe again. Refer to the official notice for the current status.
📈 Timeline
74 days in total
May 17, 2026 July 30, 2026
Daily snapshot data starts accumulating once the scheduler runs — for now this is interpolated from the agency's first/last dates.

What is this? A hair-care product called Matrix Biolage Colorcare therapie. It is a cosmetic item used to care for colored hair.

What's happening? The product contains a chemical called BMHCA. This chemical is not allowed in cosmetics. It may harm the reproductive system, unborn children, and skin.

Does this affect me? If you used this product in Italy, you may be at risk. The risk is higher if you are pregnant or planning a baby.

What should I do? Stop using the product right away. Ask your pharmacist or doctor for advice before using any more hair-care products.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Brand(s) / product name(s)
Matrix
Agency-published detail

Risk level: Serious risk · Type: Chemical · Category: Cosmetics · Hazard: According to the list of ingredients, the product contains 2-(4-tert-butylbenzyl) propionaldehyde (BMHCA), which is prohibited in cosmetic products. BMHCA can damage the reproductive system, may harm the health of the unborn child and may cause skin sensitisation. · Origin: United States

First published
March 8, 2024
Last refreshed by us
2 months ago
Severity (as classified)
High
Official source
https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10011137

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

▸ What is this product recall alert about?
Matrix — Matrix Biolage Colorcare therapie. Risk level: Serious risk · Type: Chemical · Category: Cosmetics · Hazard: According to the list of ingredients, the product contains 2-(4-tert-butylbenzyl) propionaldehyde (BMHCA), which is prohibited in cosmetic products. BMHCA can damage the reproductive system, may harm the he...
▸ When was this alert issued?
This alert was issued on March 8, 2024 by EU Safety Gate.
▸ Which countries are affected?
The alert applies to Italy.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you have this product at home, stop using it and return it to the point of purchase for a refund. Keep the receipt if you have one — most retailers refund without it for safety recalls.
▸ Where can I find the official notice?
The full official notice is published on ec.europa.eu.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.